One tanning peptide held only 40% of what its label claimed. Experts also flag infection risks as the US moves toward letting compounders make some unapproved peptides.
Recap by typeshit. Full story at Independent Journal Review.
One study cited by @fittrwithsquats put the risk of non-scarring hair loss about 40% higher with GLP-1 use, mostly telogen effluvium. Nail findings are less consistent.
European regulators first raised NAION, a rare optic nerve condition sometimes called an eye stroke, as a possible risk more than 15 months ago.
Obesity doctor Spencer Nadolsky takes on six popular misconceptions about Ozempic in a quick social video. The caption doesn't say which myths are covered.
Users described more appetite, fatigue, extra energy and insomnia. An analysis of Reddit comments, not a clinical trial, so the findings come from self-reports.
Polskie Radio reports the FDA has added a new warning to the labels of weight loss drugs, Wegovy among them. Details are at the link.
At a Pretoria roundtable, industry groups pushed police to act. SAHPRA says it has seized products, opened criminal cases and raided a compounding site in Silverton.
Loading…